Article Details
Retrieved on: 2023-11-14 14:53:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Insilico Medicine have created a drug candidate discovered using its AI platform is now entering Phase 2 clinical trials to treat idiopathic pulmonary ...
Article found on: pharmaceuticalmanufacturer.media
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here